Suppr超能文献

一种与E-钙黏蛋白相关的卵巢癌三维悬浮生长模型的构建及特征

Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer.

作者信息

Xu Shan, Yang Ya'nan, Dong Lingling, Qiu Wenlong, Yang Lu, Wang Xiuwen, Liu Lian

机构信息

Department of Chemotherapy, Cancer Center, Qilu Hospital, Shandong University, Jinan, China.

Department of Cancer, Weifang Traditional Chinese Medical Hospital, Weifang, China.

出版信息

Sci Rep. 2014 Jul 10;4:5646. doi: 10.1038/srep05646.

Abstract

Ovarian cancer is the deadliest of all gynecologic malignancies. Metastatic ovarian cancer cells exist mainly in the form of multi-cellular spheroids (MCSs) in the ascites of patients with advanced ovarian cancer. We hypothesized that E-cadherin, as an important cell-adhesion molecule, might play an important role in the formation and survival of MCSs. Therefore, we established a three-dimensional suspension culture model of ovarian cancer cells that express high levels of E-cadherin to investigate their growth, proliferation, and resistance to chemotherapeutic drugs by CCK-8 assays. Compared to the cell suspension masses formed by cells with low or absent E-cadherin expression, the MCSs of high E-cadherin SKOV-3 cells had larger volumes, tighter cellular connections, and longer survival times. Although the suspension cell masses of all three cell lines were proliferatively stagnant, possibly due to cell cycle arrest at G1/S, cell mortality at 72 h after cisplatin treatment was significantly decreased in the high E-cadherin SKOV-3 cells compared to SKOV-3 cells without E-cadherin expression and to OVCAR-3 cells with low E-cadherin expression. We conclude, therefore, E-cadherin plays a vital role in MCS formation, maintenance, and drug resistance in ovarian cancer and could be a potential target for late-stage ovarian cancer treatment.

摘要

卵巢癌是所有妇科恶性肿瘤中致死率最高的。转移性卵巢癌细胞主要以多细胞球体(MCSs)的形式存在于晚期卵巢癌患者的腹水中。我们推测,作为一种重要的细胞粘附分子,E-钙粘蛋白可能在MCSs的形成和存活中发挥重要作用。因此,我们建立了一个表达高水平E-钙粘蛋白的卵巢癌细胞三维悬浮培养模型,通过CCK-8法研究其生长、增殖及对化疗药物的耐药性。与E-钙粘蛋白表达低或缺失的细胞形成的细胞悬液团相比,高E-钙粘蛋白SKOV-3细胞的MCSs体积更大、细胞连接更紧密、存活时间更长。尽管所有三种细胞系的悬浮细胞团增殖停滞,可能是由于细胞周期停滞在G1/S期,但与无E-钙粘蛋白表达的SKOV-3细胞及E-钙粘蛋白表达低的OVCAR-3细胞相比,顺铂处理72小时后,高E-钙粘蛋白SKOV-3细胞的细胞死亡率显著降低。因此,我们得出结论,E-钙粘蛋白在卵巢癌MCSs的形成、维持及耐药性中起关键作用,可能是晚期卵巢癌治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9ca/5381612/45635710094d/srep05646-f1.jpg

相似文献

4
E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.
PLoS One. 2017 Sep 21;12(9):e0184439. doi: 10.1371/journal.pone.0184439. eCollection 2017.
8
Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.
Br J Cancer. 2013 Feb 19;108(3):579-86. doi: 10.1038/bjc.2013.10. Epub 2013 Jan 31.
9
Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
Cancer Res. 2008 Apr 1;68(7):2329-39. doi: 10.1158/0008-5472.CAN-07-5167.
10
E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway.
Acta Pharmacol Sin. 2012 Jun;33(6):817-22. doi: 10.1038/aps.2012.30. Epub 2012 Apr 30.

引用本文的文献

1
CREB Regulates Cisplatin Resistance by Targeting TNKS and KDM6A in NSCLC cell-Derived Tumor Spheroid.
Int J Biol Sci. 2025 Jul 28;21(11):4851-4871. doi: 10.7150/ijbs.109419. eCollection 2025.
4
GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells.
Front Cell Dev Biol. 2025 Jan 17;12:1511190. doi: 10.3389/fcell.2024.1511190. eCollection 2024.
7
Reproduction of the Antitumor Effect of Cisplatin and Cetuximab Using a Three-dimensional Spheroid Model in Oral Cancer.
Int J Med Sci. 2022 Jul 18;19(8):1320-1333. doi: 10.7150/ijms.74109. eCollection 2022.
9
The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.
Front Endocrinol (Lausanne). 2022 Apr 28;13:886533. doi: 10.3389/fendo.2022.886533. eCollection 2022.
10
Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma.
Adv Drug Deliv Rev. 2022 Jan;180:114067. doi: 10.1016/j.addr.2021.114067. Epub 2021 Nov 22.

本文引用的文献

2
E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway.
Acta Pharmacol Sin. 2012 Jun;33(6):817-22. doi: 10.1038/aps.2012.30. Epub 2012 Apr 30.
3
E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
Oncogene. 2011 Jun 16;30(24):2753-66. doi: 10.1038/onc.2011.6. Epub 2011 Feb 7.
4
Ovarian cancer development and metastasis.
Am J Pathol. 2010 Sep;177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22.
5
The biology of ovarian cancer: new opportunities for translation.
Nat Rev Cancer. 2009 Jun;9(6):415-28. doi: 10.1038/nrc2644.
7
Multicellular spheroids in ovarian cancer metastases: Biology and pathology.
Gynecol Oncol. 2009 Apr;113(1):143-8. doi: 10.1016/j.ygyno.2008.11.032. Epub 2009 Jan 10.
8
Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells.
Cancer Lett. 2008 Aug 18;267(1):106-15. doi: 10.1016/j.canlet.2008.03.010. Epub 2008 Apr 22.
9
Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression.
Clin Exp Metastasis. 2008;25(6):643-55. doi: 10.1007/s10585-008-9171-5. Epub 2008 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验